Accumulation of Norfloxacin by Bacteroides fragilis
- 1 September 2000
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (9) , 2361-2366
- https://doi.org/10.1128/aac.44.9.2361-2366.2000
Abstract
The accumulation of norfloxacin by Bacteroides fragilis NCTC 9343 was determined by the modified fluorescence method. The time required to achieve a steady-state concentration (SSC) after allowing B. fragilis to accumulate norfloxacin in an aerobic or an anaerobic environment was ∼2 min; the SSC achieved in air was 90.28 ± 9.32 ng of norfloxacin/mg (dry weight) of cells, and that achieved anaerobically was 98.45 ± 3.7 ng of norfloxacin/mg (dry weight) of cells. Initial rates of accumulation were determined with a range of external concentrations, as up to 8 μg/ml the concentration of norfloxacin accumulated increased proportionally to the external concentration, 12.13 ng/mg (dry weight) of cells per μg of exogenous norfloxacin per ml. At concentrations above 10 μg/ml no increase in the rate of norfloxacin accumulation was observed. From the kinetic data, a Lineweaver-Burk plot calculated a K m of 5.03 μg/ml and a V max of 25.1 ng of norfloxacin/s. With an increase in temperature of between 0 and 30°C, the concentration of norfloxacin accumulated also increased proportionally at 4.722 ng of norfloxacin/mg (dry weight) of cells/°C. At low concentrations of glucose (m -chlorophenylhydrazone (CCCP) the mean SSC of norfloxacin was increased to 116 ± 7.01 ng of norfloxacin/mg (dry weight) of cells; glucose had no significant effect in the presence of CCCP. Magnesium chloride (20 mM) decreased the SSC of norfloxacin to 40.5 ± 3.76 ng of norfloxacin per mg (dry weight) of cells. These data suggest that the mechanism of accumulation of norfloxacin by B. fragilis is similar to that of aerobic bacteria and that the fluoresence procedure is suitable for use with an anaerobic bacterium.Keywords
This publication has 28 references indexed in Scilit:
- AcrA is a highly asymmetric protein capable of spanning the periplasm 1 1Edited by I. B. HollandJournal of Molecular Biology, 1999
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- In Vitro Activity of Quinolones and Other Antimicrobial Agents Against Anaerobic BacteriaClinical Infectious Diseases, 1996
- Renal and Splenic Abscess in A Previously Healthy ChildInfectious Diseases in Clinical Practice, 1994
- Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United StatesClinical Infectious Diseases, 1993
- Factors influencing the uptake of norfloxacin by Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitinJournal of Antimicrobial Chemotherapy, 1989
- Bacteroides fragilis resistant to both metronidazole and imipenemJournal of Antimicrobial Chemotherapy, 1986
- METRONIDAZOLE-RESISTANT BACTEROIDES FROM UNTREATED PATIENTThe Lancet, 1979